Neogenix Oncology, Inc.  Bankruptcy New Filing Alert: Required Bankruptcy Report Regarding Schedules Of Assets And Liabilities, Statement Of Financial Affairs, Monthly Operating Report Or Other Periodic Report

On March 4, 2015, a required bankruptcy report regarding schedules of assets and liabilities, statement of financial affairs, monthly operating report or other periodic report was filed in the bankruptcy case of Neogenix Oncology, Inc.  and its affiliates.

The filing was assigned docket number 499 and is described on the court’s official docket as follows:

Monthly Operating Report for Filing Period 1/1/2015 – 1/31/2015 on behalf of Neogenix Oncology, Inc. Filed by Thomas J. McKee Jr.. (McKee, Thomas)

Neogenix Oncology, Inc.  filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on July 23, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Maryland. The case number for the lead bankruptcy case is 12-23557. The bankruptcy case is currently assigned to United States Bankruptcy Judge Thomas Catliota. The law firm of Greenberg Traurig, LLP is acting as lead bankruptcy counsel to Neogenix Oncology, Inc.  in the bankruptcy case.


Leave a Reply